Might learn the plans for csl112 given efficacy demonstrated in some analyses published subsequent to last mention of it by csl. Eg , for the hyperlipidimic and multiple event analysis . Garadacimab approval announcement must be any day now.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$271.75 |
Change
0.640(0.24%) |
Mkt cap ! $131.5B | |||
| Open | High | Low | Value | Volume |
| $271.53 | $272.21 | $271.24 | $22.38M | 82.39K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 22 | $271.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $271.78 | 7 | 2 |
View Market Depth
| Last trade - 10.46am 31/07/2025 (20 minute delay) ? |
| CSL (ASX) Chart |